Претраживање
Приказ резултата 1-6 од 6
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment.
(Current Medicinal Chemistry, 2019)
Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance.
(European Journal of Pharmaceutical Sciences, 2019)
New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
(Current Pharmaceutical Design, 2015)
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
(European Journal of Pharmaceutical Sciences, 2017)
C20-nor-Abietane and Three Abietane Diterpenoids from Plectranthus mutabilis Leaves as P-Glycoprotein Modulators.
(ACS Medicinal Chemistry Letters, 2022)